tert-butyl 2-(4,6-dichloropyrimidin-2-yl)pyrrolidine-1-carboxylate

Catalog No. :
ACQYEB149
CAS No. :
2080361-24-4
Molecular Formula :
C13H17Cl2N3O2
Molecular Weight :
318.20

IUPAC Name:tert-butyl 2-(4,6-dichloropyrimidin-2-yl)pyrrolidine-1-carboxylate

tert-butyl 2-(4,6-dichloropyrimidin-2-yl)pyrrolidine-1-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg97%$335.00Login to see priceInquiryInquiry
250mg97%$670.00Login to see priceInquiryInquiry
1g97%$1677.00Login to see priceInquiryInquiry
5g97%$5019.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-butyl 2-(4,6-dichloropyrimidin-2-yl)pyrrolidine-1-carboxylate
IUPAC Nametert-butyl 2-(4,6-dichloropyrimidin-2-yl)pyrrolidine-1-carboxylate
MDL No.MFCD31567463
Molecular FormulaC13H17Cl2N3O2
Molecular Weight318.20
SMILESCC(C)(C)OC(=O)N1CCCC1C1=NC(Cl)=CC(Cl)=N1
InChI KeyFMHYTFLQTBJQTO-UHFFFAOYSA-N
Synonymtert-butyl 2-(4,6-dichloropyrimidin-2-yl)pyrrolidine-1-carboxylate;1-Pyrrolidinecarboxylic acid, 2-(4,6-dichloro-2-pyrimidinyl)-, 1,1-dimethylethyl ester
CAS No.2080361-24-4

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACQYEB149 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACQYEB149 route product structure diagram
    ACQYEB1492080361-24-4
Inquiry

2. ACQYEB149 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACQYEB149 route product structure diagram
    ACQYEB1492080361-24-4
Inquiry

Comments (0)